1
ALL1
GelMEDIXYear
1
ALL1
2022DEALS // DEV.
1
ALL1
DealsCountry
1
ALL1
U.S.A1
ALL1
HTL BiotechnologyTherapeutic Area
1
ALL1
OphthalmologyStudy Phase
1
ALL1
UndisclosedDeal Type
1
ALL1
FinancingProduct Type
1
ALL1
UndisclosedDosage Form
1
ALL1
Hydrogel ImplantLead Product
1
ALL1
Hyaluronic AcidTarget
0
ALLLead Product(s) : Regenerative Medicine,Hyaluronic Acid
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Sponsor : HTL Biotechnology
Deal Size : Undisclosed
Deal Type : Financing
Details : This investment supports development of the GelMEDIX platform, which enables the delivery of therapeutics from small molecules to cell and gene therapies. HTL will produce methacrylate hyaluronic acid, a key component for specific parameters across the G...
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
March 10, 2022
Lead Product(s) : Regenerative Medicine,Hyaluronic Acid
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Sponsor : HTL Biotechnology
Deal Size : Undisclosed
Deal Type : Financing
LOOKING FOR A SUPPLIER?